AU2003209542A1 - Use of s-substituted l-crysteine for the manufacture of a medicament for the treatment of dermatological disorders - Google Patents

Use of s-substituted l-crysteine for the manufacture of a medicament for the treatment of dermatological disorders

Info

Publication number: AU2003209542A1
Authority: AU; Australia
Prior art keywords: crysteine; medicament; substituted; manufacture; treatment
Prior art date: 2002-03-11
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.): Abandoned

Application number

AU2003209542A

Other versions

AU2003209542A8 (en

Inventor

Carlo Ghisalberti

Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)

Individual

Original Assignee

Individual

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2002-03-11

Filing date

2003-03-10

Publication date

2003-09-22

2003-03-10 Application filed by Individual filed Critical Individual

2003-09-22 Publication of AU2003209542A8 publication Critical patent/AU2003209542A8/en

2003-09-22 Publication of AU2003209542A1 publication Critical patent/AU2003209542A1/en

Status Abandoned legal-status Critical Current

Links

239000003814 drug Substances 0.000 title 1
238000004519 manufacturing process Methods 0.000 title 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
- A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid or pantothenic acid
- A61K31/198—Alpha-amino acids, e.g. alanine or edetic acid [EDTA]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/08—Antiseborrheics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/10—Anti-acne agents

Landscapes

Health & Medical Sciences (AREA)
Animal Behavior & Ethology (AREA)
General Health & Medical Sciences (AREA)
Veterinary Medicine (AREA)
Chemical & Material Sciences (AREA)
Pharmacology & Pharmacy (AREA)
Public Health (AREA)
Medicinal Chemistry (AREA)
Life Sciences & Earth Sciences (AREA)
General Chemical & Material Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Engineering & Computer Science (AREA)
Dermatology (AREA)
Bioinformatics & Cheminformatics (AREA)
Organic Chemistry (AREA)
Epidemiology (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

AU2003209542A 2002-03-11 2003-03-10 Use of s-substituted l-crysteine for the manufacture of a medicament for the treatment of dermatological disorders Abandoned AU2003209542A1 (en)

Applications Claiming Priority (3)

Application Number	Priority Date	Filing Date	Title
ITMI2002A000510		2002-03-11
IT2002MI000510A ITMI20020510A1 (en)	2002-03-11	2002-03-11	TOPICAL COMPOSITIONS CONTAINING L-CISTEIN DERIVATIVES
PCT/IB2003/000857 WO2003075901A2 (en)	2002-03-11	2003-03-10	Use of s-substituted l-crysteine for the manufacture of a medicament for the treatment of dermatological disorders

Publications (2)

Publication Number	Publication Date
AU2003209542A8 AU2003209542A8 (en)	2003-09-22
AU2003209542A1 true AU2003209542A1 (en)	2003-09-22

Family

ID=11449487

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
AU2003209542A Abandoned AU2003209542A1 (en)	2002-03-11	2003-03-10	Use of s-substituted l-crysteine for the manufacture of a medicament for the treatment of dermatological disorders

Country Status (3)

Country	Link
AU (1)	AU2003209542A1 (en)
IT (1)	ITMI20020510A1 (en)
WO (1)	WO2003075901A2 (en)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US7351745B2 (en) *	2004-12-22	2008-04-01	Avon Products, Inc	Compositions and methods of their use for improving the condition and appearance of skin
CN101467991B (en) *	2007-08-02	2012-02-01	复旦大学	Uses of allyl cysteine and analogue thereof in preparing medicament for treating myocardial damage
JP6596733B2 (en) *	2015-07-14	2019-10-30	学校法人日本大学	COMPOUND, PROTEIN MODIFICATION REAGENT CONTAINING THE COMPOUND, AND METHOD FOR LABELING PROTEIN
US20180362456A1 (en) *	2015-12-07	2018-12-20	Ems S/A	New compounds with antioxidant and antiaging activity
JP7356707B2 (en) *	2018-11-15	2023-10-05	国立大学法人神戸大学	Method for producing amino acid-N-carboxylic acid anhydride
CN115501125A (en) *	2022-10-20	2022-12-23	澳门科技大学	H for repairing skin lesions 2 S donor gel and H 2 Preparation method of S donor gel

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
BE733993A (en) *	1968-06-14	1969-12-03
US3671643A (en) *	1969-09-15	1972-06-20	Oreal	Treatment of excessive sebaceous glands secretion with substituted cysteamine compounds
BE788945A (en) *	1971-09-20	1973-03-19	Oreal
FR2155776B1 (en) *	1971-10-04	1974-11-15	Rech Pharmaceut Scient
FR2187326B1 (en) *	1972-06-15	1975-10-17	Rech Pharm Scientifiques
US4827016A (en) *	1985-09-16	1989-05-02	Morgan Lee R	Method and compounds for reducing dermal inflammations

2002
- 2002-03-11 IT IT2002MI000510A patent/ITMI20020510A1/en unknown
2003
- 2003-03-10 WO PCT/IB2003/000857 patent/WO2003075901A2/en not_active Application Discontinuation
- 2003-03-10 AU AU2003209542A patent/AU2003209542A1/en not_active Abandoned

Also Published As

Publication number	Publication date
WO2003075901A3 (en)	2003-12-31
ITMI20020510A1 (en)	2003-09-11
ITMI20020510A0 (en)	2002-03-11
AU2003209542A8 (en)	2003-09-22
WO2003075901A2 (en)	2003-09-18

Similar Documents

Publication	Publication Date	Title
AU2003279338A1 (en)	2004-05-25	Phenethanolamine derivatives for the treatment of respiratory diseases
AU2003270903A1 (en)	2004-04-19	A video game for assisting healing of the human body
AU2003291992A1 (en)	2004-05-25	Phenylethanolamine derivatives for the treatment of respiratory diseases
AU2003286567A1 (en)	2004-05-13	Methods for the treatment of skin disorders
HUS1400011I1 (en)	2022-02-28	Novel medicaments for the treatment of chronic obstructive pulmonary diseases
AU2003210428A1 (en)	2003-09-09	Phenethanolamine derivatives for treatment of respiratory diseases
AU2003300791A1 (en)	2004-07-09	Combination therapy for the treatment of pain
AU2003228819A1 (en)	2003-11-17	Combinations for the treatment of inflammatory skin disorders
AU2003286728A1 (en)	2004-06-07	Compounds for the treatment of metabolic disorders
AU2003235798A1 (en)	2003-07-24	Use of a gsk-3beta inhibitor in the manufacture of a medicament for increasing bone formation
AU2003223684A1 (en)	2003-11-10	Lxr modulators for the treatment of cardiovascular diseases
AU2002338303A1 (en)	2002-10-28	Therapeutic compositions for the treatment of a respiratory tract disease
AU2003278559A1 (en)	2004-05-04	Herbal medicine containing cyclodextrins for the treatment of ear disorders
AU2003209542A1 (en)	2003-09-22	Use of s-substituted l-crysteine for the manufacture of a medicament for the treatment of dermatological disorders
ZA200405853B (en)	2008-10-29	Use of adapalene for the treatment of dermatological disorders
AU2003303217A1 (en)	2004-07-14	Use of substituted 2,5-diamidoindoles for the treatment of urological diseases
AU2003289652A1 (en)	2004-07-09	The use of compound helicid for manufacturing medicine to treat depresion and/or disorders caused by depresion
AU2003205898A1 (en)	2003-09-04	Combination therapy for respiratory disorders
IL162509A (en)	2010-06-16	Use of deoxypeganine for the production of a drug for treating clinical depression
AU2003296545A1 (en)	2004-07-09	Use of a trpm8-activating substance for the treatment of tumours
AU2003274703A1 (en)	2004-04-23	Use of propionyl l-carnitine for the preparation of a medicament for the treatment of glaucoma
AU2003242517A1 (en)	2004-02-02	A handpiece for tissue treatment
AU2003301758A1 (en)	2004-05-25	Use of pyrimidine derivates for the manifacture of a medicament for the treatment of hyper-proliferative disorders
AU2003274885A1 (en)	2004-06-07	Phenyl-piperidin-4-ylidene-methyl-benzamide derivatives for the treatment of pain or gastrointestinal disorders
AU2002307327A1 (en)	2002-11-18	Use of an ampa receptor potentiator for the manufacture of a medicament for the treatment of type 2 diabetes

Legal Events

Date	Code	Title	Description
2004-11-25	MK6	Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase